The DOI matches its Crossref record, with a small difference in title or year; 29 of the 29 references it cites were found in a registry or an index.
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative. OBJECTIVE: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. DESIGN, SETTING, AND PARTICIPANTS: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock. INTERVENTIONS: Patients were randomly allocated to vasopressin (titrated up to 0.06 U/min) and hydrocortisone (n = 101), vasopressin and placebo (n = 104), norepinephrine and hydrocortisone (n = 101), or norepinephrine and placebo (n = 103). MAIN OUTCOMES AND MEASURES: The primary outcome was kidney failure-free days during the 28-day period after randomization, measured as (1) the proportion of patients who never developed kidney failure and (2) median number of days alive and free of kidney failure for patients who did not survive, who experienced kidney failure, or both. Rates of renal replacement therapy, mortality, and serious adverse events were secondary outcomes. RESULTS: A total of 409 patients (median age, 66 years; men, 58.2%) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock. The number of survivors who never developed kidney failure was 94 of 165 patients (57.0%) in the vasopressin group and 93 of 157 patients (59.2%) in the norepinephrine group (difference, -2.3% [95% CI, -13.0% to 8.5%]). The median number of kidney failure-free days for patients who did not survive, who experienced kidney failure, or both was 9 days (interquartile range [IQR], 1 to -24) in the vasopressin group and 13 days (IQR, 1 to -25) in the norepinephrine group (difference, -4 days [95% CI, -11 to 5]). There was less use of renal replacement therapy in the vasopressin group than in the norepinephrine group (25.4% for vasopressin vs 35.3% for norepinephrine; difference, -9.9% [95% CI, -19.3% to -0.6%]). There was no significant difference in mortality rates between groups. In total, 22 of 205 patients (10.7%) had a serious adverse event in the vasopressin group vs 17 of 204 patients (8.3%) in the norepinephrine group (difference, 2.5% [95% CI, -3.3% to 8.2%]). CONCLUSIONS AND RELEVANCE: Among adults with septic shock, the early use of vasopressin compared with norepinephrine did not improve the number of kidney failure-free days. Although these findings do not support the use of vasopressin to replace norepinephrine as initial treatment in this situation, the confidence interval included a potential clinically important benefit for vasopressin, and larger trials may be warranted to assess this further. TRIAL REGISTRATION: clinicaltrials.gov Identifier: ISRCTN 20769191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution (277,279).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [279]
Experimental — accuracy not yet measuredIn the citing paper
“Although there was no difference with respect to kidney injury (RR 0.89; 95% CI 0.72–1.11), vasopressin use reduced the risk of RRT (RR 0.71; 95% CI 0.53–0.97) [354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“There was no significant difference between the vasopressin and norepinephrine groups in 28-day mortality [30.9% vs 27.5%; RR 1.13 (95% CI 0.85–1.51).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS [353, 354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,335
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,046
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R. P., Singer, M., Freivogel, K., Weiss, Y., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,179
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citationHigh versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Cited by
Sorted by citations
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationCecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
Self-citationPeerapornratana, S., Manrique‐Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,557
Global epidemiology and outcomes of acute kidney injury
Hoste, E. A. J., Kellum, J. A., Selby, N. M., Zarbock, A., Palevsky, P. M., Bagshaw, S. M., Goldstein, S. L., Cerdá, J., & Chawla, L. S. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0052-0 · Cited by 1,486
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 917
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Bellomo, R., Kellum, J. A., Ronco, C., Wald, R., Mårtensson, J., Maiden, M. J., Bagshaw, S. M., Glassford, N. J., Lankadeva, Y. R., Vaara, S. T., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4755-7 · Cited by 794
Acute kidney injury in the critically ill: an updated review on pathophysiology and management
Pickkers, P., Darmon, M., Hoste, E. A. J., Joannidis, M., Legrand, M. M., Ostermann, M., Prowle, J. R., Schneider, A. G., & Schetz, M. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06454-7 · Cited by 602
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005357 · Cited by 513
Self-citationReappraisal of Ventilator-Free Days in Critical Care Research
Yehya, N., Harhay, M. O., Curley, M. A. Q., Schoenfeld, D., & Reeder, R. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-2050cp · Cited by 395
Antcliffe, D. B., Burnham, K. L., Al-Beidh, F., Santhakumaran, S., Brett, S. J., Hinds, C., Ashby, D., Knight, J. C., & Gordon, A. C. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1419oc · Cited by 387
Self-citationLevosimendan for the Prevention of Acute Organ Dysfunction in Sepsis
Gordon, A. C., Perkins, G. D., Singer, M., McAuley, D. F., Orme, R. M. L., Santhakumaran, S., Mason, A. J., Cross, M., Al-Beidh, F., Best-Lane, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609409 · Cited by 372
Self-citationJoannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honoré, P. M., Hoste, E. A. J., Ostermann, M., Straaten, H. M. O., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 356
Sepsis-Associated Acute Kidney Injury
Manrique‐Caballero, C. L., Rio‐Pertuz, G. D., & Gómez, H. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2020.11.010 · Cited by 347
Surviving sepsis campaign: research priorities for sepsis and septic shock
Coopersmith, C. M., Backer, D. D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martín‐Loeches, I., Nunnally, M., Antonelli, M. M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5175-z · Cited by 292
Shankar‐Hari, M., Harrison, D. A., Rubenfeld, G. D., & Rowan, K. (2017) · British Journal of Anaesthesia · doi:10.1093/bja/aex234 · Cited by 281
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
Rochwerg, B. N., Oczkowski, S. J. W., Siemieniuk, R. A. C., Agoritsas, T., Belley‐Côté, E. P., D’Aragon, F., Duan, E. H., English, S. W., Gossack-Keenan, K. L., Alghuroba, M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003262 · Cited by 264
The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?
Moreno, R. P., Rhodes, A., Piquilloud, L., Glenn Hernández, P., Takala, J. A., Gershengorn, H. B., Tavares, M., Coopersmith, C. M., Myatra, S. N., Singer, M., et al. (2023) · Critical Care · doi:10.1186/s13054-022-04290-9 · Cited by 258
Chaudhuri, D., Nei, A. M., Rochwerg, B. N., BALK, R. A., Asehnoune, K., Cadena, R. S., Carcillo, J. A., Correa, R., Drover, K., Esper, A. M., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006172 · Cited by 262
Vasoplegia treatments: the past, the present, and the future
Lévy, B., Fritz, C., Tahon, E., Jacquot, A., Auchet, T., & Kimmoun, A. (2018) · Critical Care · doi:10.1186/s13054-018-1967-3 · Cited by 252
Management of Refractory Vasodilatory Shock
Jentzer, J. C., Vallabhajosyula, S., Khanna, A. K., Chawla, L. S., Busse, L. W., & KASHANI, K. B. (2018) · CHEST Journal · doi:10.1016/j.chest.2017.12.021 · Cited by 241
Vasopressor therapy in critically ill patients with shock
Russell, J. A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05801-z · Cited by 247
Subphenotypes in critical care: translation into clinical practice
Reddy, K., Sinha, P., O’Kane, C. M., Gordon, A. C., Calfee, C. S., & McAuley, D. F. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30124-7 · Cited by 238
Self-citationBusse, L. W., Barker, N. A., & Petersen, C. (2020) · Critical Care · doi:10.1186/s13054-020-2743-8 · Cited by 242
Sepsis and septic shock: Guideline-based management
Dugar, S. P., Choudhary, C., & Duggal, A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.18143 · Cited by 248
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 232
McIntyre, W. F., Um, K. J., Alhazzani, W., Lengyel, A. P., Hajjar, L., Gordon, A. C., Lamontagne, F., Healey, J. S., Whitlock, R. P., & Belley-Côté, E. P. (2018) · JAMA · doi:10.1001/jama.2018.4528 · Cited by 225
Self-citationBhatraju, P. K., Zelnick, L. R., Herting, J. R., Katz, R., Mikacenic, C. R., Harju-Baker, S., Morrell, E. D., Robinson‐Cohen, C., Calfee, C. S., Christie, J. D., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1346oc · Cited by 219
Rygård, S. L., Butler, E., Granholm, A., Møller, M. H., Cohen, J., Finfer, S., Perner, A., Myburgh, J., Venkatesh, B., & Delaney, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5197-6 · Cited by 211
Current use of vasopressors in septic shock
Scheeren, T., Bakker, J., Backer, D. D., Annane, D., Asfar, P., Boerma, E. C., Cecconi, M., Dubín, A., Dünser, M. W., Duranteau, J., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0498-7 · Cited by 204
Self-citationSepsis and septic shock: current approaches to management
Thompson, K., Venkatesh, B., & Finfer, S. R. (2019) · Internal Medicine Journal · doi:10.1111/imj.14199 · Cited by 207
Vasoplegia After Cardiovascular Procedures—Pathophysiology and Targeted Therapy
Shaefi, S., Mittel, A. M., Klick, J. C., Evans, A. S., Ivascu, N. S., Gutsche, J. T., & Augoustides, J. G. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.10.032 · Cited by 189
A plea for personalization of the hemodynamic management of septic shock
Backer, D. D., Cecconi, M., Chew, M. S., Hajjar, L. A., Monnet, X., Ospina-Tascón, G. A., Ostermann, M., Pinsky, M. R., & Vincent, J. (2022) · Critical Care · doi:10.1186/s13054-022-04255-y · Cited by 187
Self-citationAssociation of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis
Fang, F., Zhang, Y., Tang, J., Lunsford, L. D., Li, T., Tang, R., He, J., Xu, P., Faramand, A. M., Xu, J., et al. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5849 · Cited by 189
An updated “norepinephrine equivalent” score in intensive care as a marker of shock severity
Kotani, Y., Gioia, A. D., Landoni, G., Belletti, A., & Khanna, A. K. (2023) · Critical Care · doi:10.1186/s13054-023-04322-y · Cited by 186
Vincent, J., Nielsen, N. D., Shapiro, N. I., Gerbasi, M. E., Grossman, A., Doroff, R., Zeng, F., Young, P. J., & Russell, J. A. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0448-9 · Cited by 174
Corticosteroids for treating sepsis in children and adults
Annane, D., Bellissant, É., Bollaert, P. E., Briegel, J., Keh, D., Kupfer, Y. Y., Pirracchio, R., & Rochwerg, B. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub4 · Cited by 178
Vasopressor dose equivalence: A scoping review and suggested formula
Goradia, S., Sardaneh, A. A., Narayan, S. W., Penm, J. H.-D., & Patanwala, A. E. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.11.002 · Cited by 175
Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis
Stolk, R. F., van der Pasch, E., Naumann, F. V., Schouwstra, J., Bressers, S., van Herwaarden, A. E., Gerretsen, J., Schambergen, R., Ruth, M. M., van der Hoeven, J. G., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0339oc · Cited by 177
Update of Sepsis in the Intensive Care Unit
Genga, K. R., & Russell, J. A. (2017) · Journal of Innate Immunity · doi:10.1159/000477419 · Cited by 167
Nagendran, M., Russell, J. A., Walley, K. R., Brett, S. J., Perkins, G. D., Hajjar, L., Mason, A. J., Ashby, D., & Gordon, A. C. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05620-2 · Cited by 161
Self-citationAcute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies
Gameiro, J., Fonseca, J. A., Outerelo, C., & Lopes, J. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061704 · Cited by 192
Current practice and evolving concepts in septic shock resuscitation
Bakker, J., Kattan, E., Annane, D., Castro, R., Cecconi, M., Backer, D. D., Dubín, A., Evans, L., Gong, M. N., Hamzaoui, O., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06595-9 · Cited by 158
Self-citationPathophysiology of Septic Shock
Russell, J. A., Rush, B. N. M., & Boyd, J. H. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.005 · Cited by 147
Pais, T., Jorge, S. C., & Lopes, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115924 · Cited by 157
A global perspective on vasoactive agents in shock
Annane, D., Ouanes-Besbes, L., Backer, D. D., Du, B., Gordon, A. C., Glenn Hernández, P., Olsen, K. M., Osborn, T. M., Peake, S., Russell, J. A., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5242-5 · Cited by 147
Self-citationVasopressin and its analogues in shock states: a review
Demiselle, J., Fage, N., Radermacher, P., & Asfar, P. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0628-2 · Cited by 137
Sacha, G. L., Lam, S. W., Wang, L., Duggal, A., Reddy, A. J., & Bauer, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005317 · Cited by 135
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
Prescott, H. C., Antonelli, M. M., Alhazzani, W. A., Møller, M. H., Alshamsi, F. E., Azevedo, L. C. P., Belley‐Côté, E. P., Waele, J. D., Derde, L. P. G., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 149
Self-citationLiu, Z.-M., Chen, J., Kou, Q., Lin, Q., Huang, X., Tang, Z., Kang, Y., Li, K., Zhou, L., Song, Q., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5267-9 · Cited by 127
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 128
Vasopressors in septic shock: which, when, and how much?
Shi, R., Hamzaoui, O., Vita, N. D., Monnet, X., & Teboul, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.24 · Cited by 126
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationSurviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock
Coopersmith, C. M., Backer, D. D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martín‐Loeches, I., Nunnally, M., Antonelli, M. M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003225 · Cited by 117
Fujii, T., Salanti, G., Belletti, A., Bellomo, R., Carr, A. C., Furukawa, T. A., Luethi, N., Luo, Y., Putzu, A., Sartini, C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06558-0 · Cited by 115
American Burn Association Clinical Practice Guidelines on Burn Shock Resuscitation
Cartotto, R. C., Johnson, L. S., Savetamal, A., Greenhalgh, D. G., Kubasiak, J., Pham, T. N., Rizzo, J. A., Sen, S., & Main, E. (2023) · Journal of Burn Care & Research · doi:10.1093/jbcr/irad125 · Cited by 109
Fluid resuscitation in human sepsis: Time to rewrite history?
Byrne, L., & van Haren, F. M. P. (2017) · Annals of Intensive Care · doi:10.1186/s13613-016-0231-8 · Cited by 107
Russell, J. A., Vincent, J.-L., Kjølbye, A. L., Olsson, H., Blemings, A., Spapen, H., Carl, P., Laterre, P.-F., & Grundemar, L. (2017) · Critical Care · doi:10.1186/s13054-017-1798-7 · Cited by 103
Wani, S. J., Mufti, S. A., Jan, R. A., Shah, S. U., Qadri, S. M., Khan, U. H., Bagdadi, F. S., Mehfooz, N., & Koul, P. A. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1718200 · Cited by 104
A consensus immune dysregulation framework for sepsis and critical illnesses
Moore, A. R., Zheng, H., Ganesan, A., Hasin-Brumshtein, Y., Maddali, M. V., Levitt, J. E., van der Poll, T., Lu, J., Bouma, H. R., Scicluna, B. P., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03956-5 · Cited by 110
Vasopressor Therapy in the Intensive Care Unit
Russell, J. A., Gordon, A. C., Williams, M. D., Boyd, J. H., Walley, K. R., & Kissoon, N. “. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1710320 · Cited by 99
Self-citationSepsis subphenotypes, theragnostics and personalized sepsis care
Antcliffe, D. B., Burrell, A. J. C., Boyle, A. J., Gordon, A. C., McAuley, D. F., & Silversides, J. A. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07873-6 · Cited by 99
Self-citationde Grooth, H.-J., Postema, J., Loer, S. A., Parienti, J.-J., Oudemans-van Straaten, H. M., & Girbes, A. R. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5134-8 · Cited by 92
Datt, V., Wadhhwa, R., Sharma, V., Virmani, S., Minhas, H. S., & Malik, S. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15805 · Cited by 87
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 88
Sepsis-induced AKI: From pathogenesis to therapeutic approaches
He, F.-F., Wang, Y., Chen, Y., Huang, W. C., Li, Z., & Zhang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981578 · Cited by 86
Sepsis and Septic Shock Strategies
Armstrong, B., Betzold, R., & May, A. K. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.07.003 · Cited by 88
Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock*
Roberts, R. J., Miano, T. A., Hammond, D. A., Patel, G. P., Chen, J., Phillips, K. M., Lopez, N. D., KASHANI, K. B., Qadir, N., Cairns, C. B., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004476 · Cited by 86
Predictors of response to fixed-dose vasopressin in adult patients with septic shock
Sacha, G. L., Lam, S. W., Duggal, A., Torbic, H., Bass, S. N., Welch, S. C., Butler, R. S., & Bauer, S. R. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0379-5 · Cited by 84
Ding, Y., Zheng, Y., Huang, J., Peng, W., Chen, X., Kang, X., & Zeng, Q. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.043 · Cited by 82
Bosch, N. A., Teja, B. J., Law, A. C., Pang, B., Jafarzadeh, S. R., & Walkey, A. J. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0258 · Cited by 79
Vasopressor and Inotrope Therapy in Cardiac Critical Care
Jentzer, J. C., & Hollenberg, S. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620917630 · Cited by 77
Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations
Tamargo, C. L., Hanouneh, M. A., & Cervantes, C. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092455 · Cited by 81
A consensus blood transcriptomic framework for sepsis
Scicluna, B. P., Cano-Gamez, K., Burnham, K. L., Davenport, E. E., Moore, A. R., Khan, S., Hinds, C., Cremer, O. L., Khatri, P., Sweeney, T. E., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03964-5 · Cited by 80
The intensive care medicine research agenda on septic shock
Perner, A., Gordon, A. C., Angus, D. C., Lamontagne, F., Machado, F. R., Russell, J. A., Timsit, J., Marshall, J. C., Myburgh, J., Shankar‐Hari, M., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4821-1 · Cited by 78
Self-citationMi, Y., Burnham, K. L., Charles, P. D., Heilig, R., Vendrell, I., Whalley, J. P., Torrance, H. D. T., Antcliffe, D. B., May, S. M., Neville, M. J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adh0185 · Cited by 77
Self-citationBottari, G., Ranieri, V. M., İnce, C., Pesenti, A., Aucella, F., Scandroglio, A. M., Ronco, C., & Vincent, J. (2024) · Critical Care · doi:10.1186/s13054-024-05220-7 · Cited by 72
Timing of vasoactive agents and corticosteroid initiation in septic shock
Ammar, M. A., Ammar, A. A., Wieruszewski, P. M., Bissell, B. D., Long, M. T., Albert, L., Khanna, A. K., & Sacha, G. L. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01021-9 · Cited by 72
Prowle, J. R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07310717 · Cited by 68
Hammond, D. A., Ficek, O. A., Painter, J. T., McCain, K., Cullen, J., Brotherton, A. L., Kakkera, K. S. S., Chopra, D., & Meena, N. K. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2105 · Cited by 66
Immune therapy in sepsis: Are we ready to try again?
Davies, R., O'Dea, K. P., & Gordon, A. C. (2018) · Journal of the Intensive Care Society · doi:10.1177/1751143718765407 · Cited by 68
Self-citationSartelli, M., Tascini, C., Coccolini, F., Dellai, F., Ansaloni, L., Antonelli, M. M., Bartoletti, M., Bassetti, M., Boncagni, F., Carlini, M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00551-w · Cited by 66
ELABELA Improves Cardio-Renal Outcome in Fatal Experimental Septic Shock
Coquerel, D., Chagnon, F., Sainsily, X., Dumont, L., Murza, A., Côté, J., Dumaine, R., Sarret, P., Marsault, É., Salvail, D., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002639 · Cited by 62
Host and Microbe Blood Metagenomics Reveals Key Pathways Characterizing Critical Illness Phenotypes
Neyton, L. P. A., Sinha, P., Sarma, A. A., Mick, E., Kalantar, K., Chen, S., Wu, N., Delucchi, K., Zhuo, H., Bos, L. D. J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202308-1328oc · Cited by 62
Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors
Riccardi, M., Pagnesi, M., Chioncel, O. D., Mebazaa, A., Cotter, G., Gustafsson, F., Tomasoni, D., Latronico, N., Adamo, M., & Metra, M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3162 · Cited by 59
Hajjar, L. A., Zambolim, C. M., Belletti, A., de Almeida, J. P., Gordon, A. C., Oliveira, G., Park, C. H. L., Fukushima, J. T., Rizk, S. I., Szeles, T. F., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004023 · Cited by 63
Self-citationAntcliffe, D. B., Santhakumaran, S., Orme, R., Ward, J. K., Al-Beidh, F., O'Dea, K. P., Perkins, G. D., Singer, M., McAuley, D. F., Mason, A. J., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05731-w · Cited by 58
Self-citationJeon, K., Song, J., Chung, C. R., Yang, J. H., & Suh, G. Y. (2018) · Critical Care · doi:10.1186/s13054-018-2034-9 · Cited by 56
Okazaki, N., Iguchi, N., Evans, R. G., Hood, S. G., Bellomo, R., May, C. N., & Lankadeva, Y. R. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004511 · Cited by 55
Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 61
Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury
Busse, L. W., & Ostermann, M. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.06.006 · Cited by 52
Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
Fage, N., Asfar, P., Radermacher, P., & Demiselle, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044103 · Cited by 54
Corticosteroids for Treating Sepsis in Adult Patients: A Systematic Review and Meta-Analysis
Liang, H., Song, H., Zhai, R., Song, G., Li, H., Ding, X., Kan, Q., & Sun, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.709155 · Cited by 52
Sartelli, M., Barie, P. S., Agnoletti, V., Al‐Hasan, M. N., Ansaloni, L., Biffl, W. L., Buonomo, L. A., Blot, S. I., Cheadle, W. G., Coimbra, R. S. M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00552-9 · Cited by 54
External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients
Wong, H. R., Hart, K. W., Lindsell, C. J., & Sweeney, T. E. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004709 · Cited by 50
Lesur, O., Delile, E., Asfar, P., & Radermacher, P. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0449-8 · Cited by 53
Teja, B., Berube, M., Pereira, T. V., Law, A. C., Schanock, C., Pang, B., Wunsch, H., Walkey, A. J., & Bosch, N. A. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202310-1785oc · Cited by 48
Metadata
- Authors
- Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., Santhakumaran, S., Ashby, D., Brett, S. J., & for the VANISH Investigators
- Affiliations
- Imperial College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Warwick (GB)
- National Health Service (GB)
- Corresponding author
- Gordon, Anthony C.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-08-02
- Volume
- 316
- Issue
- 5
- Pages
- 509
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2489536306
- Semantic Scholar
- 0a2e8f0595aed35457448e71c5f52e2cd0ccb618
- Cited by
- 728
- References
- 29
- Citations by year
- 2026: 77 · 2025: 114 · 2024: 82 · 2023: 69 · 2022: 59 · 2021: 61 · 2020: 67 · 2019: 83 · 2018: 62 · 2017: 40 · 2016: 12
- FWCI
- 61.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- University of Brighton Repository (University of Brighton) (publishedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Warwick Research Archive Portal (University of Warwick) (submittedVersion)
- Funders
- University of Portsmouth
- Intensive Care Foundation
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health and Care Research (NF-SI-0514-10139, NIHR/CS/009/007, PB-PG-0610-22350)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Barts Health NHS Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- septic shock, vasopressin, norepinephrine, renal failure, acute kidney injury, vasopressor therapy, cortisol, renal replacement therapy, mortality, intensive care unit patients, fluid resuscitation, serious adverse events, 90-day outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Critical Care, Double-Blind Method, Drug Administration Schedule, Female, Fluid Therapy, United Kingdom, Humans, Hydrocortisone, Intensive Care Units, Male, Middle Aged, Norepinephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome, Renal Replacement Therapy, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
